Cargando…
Clinical and Genetic Features of Chinese Patients With NIPA1-Related Hereditary Spastic Paraplegia Type 6
Background: Mutations in the NIPA1 gene cause hereditary spastic paraplegia (HSP) type 6 (SPG6), which is a rare type of HSP with a frequency of less than 1% in Europe. To date, less than 30 SPG6 families and limited NIPA1 mutations have been reported in different ethnic regions. The clinical featur...
Autores principales: | Fu, Jun, Ma, Mingming, Li, Gang, Zhang, Jiewen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9024055/ https://www.ncbi.nlm.nih.gov/pubmed/35464835 http://dx.doi.org/10.3389/fgene.2022.859688 |
Ejemplares similares
-
Clinical and genetic characterization of NIPA1 mutations in a Taiwanese cohort with hereditary spastic paraplegia
por: Fang, Shih‐Yu, et al.
Publicado: (2023) -
Clinical features and genetic spectrum of Chinese patients with hereditary spastic paraplegia: A 14-year study
por: Yu, Weiyi, et al.
Publicado: (2023) -
The hereditary spastic paraplegia proteins NIPA1, spastin and spartin are inhibitors of mammalian BMP signalling
por: Tsang, Hilda T.H., et al.
Publicado: (2009) -
Clinical features and genetic spectrum in Chinese patients with recessive hereditary spastic paraplegia
por: Wei, Qiao, et al.
Publicado: (2019) -
Challenges and Controversies in the Genetic Diagnosis of Hereditary Spastic Paraplegia
por: Saputra, Lydia, et al.
Publicado: (2021)